Close Price
60.50
Fair Value
73.79
Valuation
UndervaluedUncertainty
High
60.50
73.79
High
—
Thanks for your feedback.
INR | In Millions except percentages and ratios. Fiscal Year-End March 31.
Income Statement as of 09/30/2024 is reflective of TTM. Balance Sheet as of 03/31/2024 is reflective of Quater-End. Cash Flow Statement as of 09/30/2024 is reflective of TTM.
Normalized EPS represents earnings per share adjusted for income/expenses that are considered irregular, unusual or non-recurring. The adjustment values are usually reported in the notes to financial statements, management, discussion and analysis or as Non-Gaap metrics. This is an analyst-screened datapoint, meaning an analyst is identifying and taking judgment on what should or should not be adjusted.
Fair Value Assessment
Currency in INR. Updated as of Mar 18, 2025.
Price Chart
National Stock Exchange of India: REXPIPES | Last close price updated as of Mar 21, 2025, 12:13 PM IST | INR
Undervalued
Morningstar Rating
Updated as of Mar 22, 2025.
Close Price
Updated as of Mar 21, 2025.
Fair Value Assessment
Currency in INR. Updated as of Mar 18, 2025.
Not Rated
Any stock that has its price data missing for more than a month (30 calendar days), its rating is removed.
Under Review
For any corporate action* we update the star rating value to the Under Review (6) label for all share classes from T-1 (business days) until the next fair value calculation (Saturday 10 AM CST).
If the QFVP value is out of the expected range of 0.25-4, the model anticipates that the stock has observed some turbulence that would require us to re-evaluate the rating. From this point until the next adjustment of QFVP these are classified as Under Review.
If price data is available in the last 1 month, but older than 7 days, we place the company Under Review.